CAS: 1197-22-4; N-Phenylmethanesulfonamide

该化合物是一种磺酰胺衍生物,其特点是甲烷硫氨酸盐的氮原子中含有一个联苯组,该化合物通常用作有机合成的中间体,特别是在制备药品,农用化学品和特殊化学品方面,其主要优点包括:在标准条件下具有稳定性,符合一系列反应条件,以及它作为进一步功能化的多用途建筑块的作用.

结构式图片

相似化合物

68-34-8 53250-82-1 37045-73-1

欧盟法规

REACH注册ECHA物质C&L通报REACH预注册

上下游产品

CAS号124-63-0 甲基磺酰氯 | CAS号3144-09-0 甲基磺酰胺 | CAS号108-94-1 环己酮 | CAS号624-90-8 Azidomethane | CAS号98-80-6 苯硼酸 | CAS号108-86-1 溴苯 | CAS号108-90-7 氯苯 | CAS号591-50-4 碘苯 | CAS号112010-98-7 N-phenyl-S-viny... | CAS号4284-50-8 N-(4-溴苯基)甲磺酰胺 | CAS号5577-42-4 N-[4-(2-溴乙酰基)苯基]甲磺酰胺 | CAS号206-55-3 indeno[1,2,3-de... | CAS号22729-75-5 N-phenyl-N-[(1,... | CAS号91-22-5 喹啉 | CAS号35980-24-6 N‐(4‐fluorophen... | CAS号98611-90-6 N-(2-氟苯基)甲磺酰胺 | CAS号5317-89-5 N-(4-乙酰基苯基)甲磺酰胺

合成工艺路线路线简述

  • 合成目标产物 N-Phenylmethanesulfonamide 主要起始原料 Methanesulfonamide And Phenylboronic Acid
  • (文献来源)合成步骤主要原料 Methanesulfonamide 和 Phenylboronic Acid
甲磺酰胺,N-(2-碘苯基)-置于n-Ethylpiperidine Hypophosphite,偶氮二异丁腈,Sodium Hydride体系中,用 N,N-二甲基甲酰胺,苯 用作溶剂,化学反应 5.25H,反应生成N-苯基甲磺酰胺
参考文献:A Radical Based Addition-elimination Route For The Preparation Of Indoles
标题:A Radical Based Addition-elimination Route For The Preparation Of Indoles
摘要:包括三环衍生物在内的吲哚,是通过将芳基自由基环化到乙烯基卤化物上,随后消除卤素自由基以及生成的产物的互变异构作用产生的;这些芳基自由基是通过"清洁方法学"生成的,或者是通过碘离子与芳二氮鎓盐的反应,或者是通过磷中心自由基与芳基碘的反应.
Doi:10.1039/b002565H

专利信息


专利号:US-8901352-B2
优先权日:2011-01-13
标题 :Method for the synthesis of rasagiline
发明人:REIS ÖMER; KOYUNCU HASAN; ESIRINGU ILKER; SAHIN YASEMIN; GULCAN H OZAN
权利人:REIS ÖMER; KOYUNCU HASAN; ESIRINGU ILKER; SAHIN YASEMIN; GULCAN H OZAN; NOBEL ILAÇ SANAYII VE TICARET A S
摘要:We have developed a new method for the synthesis of Rasagiline (Formula 1) based on the alkylation of trifluoroacetyl protected aminoindan. This protection enabled us to carry out an alkylation of aminoindan with a high yield and purity under very mild conditions with a wide range of reaction conditions and reagent selection. Considering the ease, purity and high yields of introducing and removal of the trifluoroacetyl group, this approach is a highly practical and economical way for the synthesis of rasagiline or its pharmaceutically acceptable salts.

专利号:WO-9013609-A1
优先权日:1989-05-01
标题 :Novel fluorescent pigment compositions and a process for their preparation and use of same
发明人:MALLAVARAPU LEO X
权利人:MALLAVARAPU LEO X
摘要:A process is disclosed for producing novel fluorescent pigment compositions with no formaldehyde or para-formaldehyde during their synthesis. The synthesis of these compositions is, for example, achieved by using an in situ reaction of epoxy resins of preferably up to a molecular weight of 20,000 with a sulfonamide compound, e.g., toluene sulfonamide, in the presence of a Lewis acid catalyst, followed by, preferably, the further reaction with an isocyanate, e.g., aliphatic isocyanate and/or para-toluene sulfonyl isocyanate. During this reaction, a fluorescent dye is incorporated into the molten mass.

专利号:US-2004110228-A1
优先权日:2002-04-01
标 题:Combinatorial organic synthesis of unique biologically active compounds
发明人:MCALPINE SHELLI R; TAYLOR RACHEL E; BOLLA MEGAN L; SEGALL ANCA M
摘要:The invention provides a method for making a combinatorial library of cyclic compounds, such as Holliday junction-trapping compounds, comprising the steps of (a) obtaining a plurality of trimers according to the generic structure X 1- X 2- X 3 , wherein X 1 , X 2 and X 3 can be independently any naturally or nonnaturally occurring amino acids or peptidomimetics thereof; (b) optionally coupling a spacer S to the trimer at either end; (c) cyclizing two trimers or trimer-spacer conjugates in a head-to-tail orientation; thereby obtaining a combinatorial library of compounds, wherein the library does not include an unmodifed or naturally occurring Holliday Junction-trapping compounds. The invention additionally provides methods macrocyclic compounds that are synergimycin derivatives.

专利号:US-5783577-A
优先权日:1995-09-15
标题 :Synthesis of quinazolinone libraries and derivatives thereof
发明人:HOUGHTEN RICHARD A; OSTRESH JOHN M
权利人:TREGA BIOSCIENCES INC
摘要:The present invention provides synthetic combinatorial libraries of organic compounds based on the quinazolinone ring.

专利号:US-8461298-B2
优先权日:2004-11-01
标 题:Compositions and methods for modification of biomolecules
发明人:BERTOZZI CAROLYN R; AGARD NICHOLAS J; PRESCHER JENNIFER A; BASKIN JEREMY MICHAEL
权利人:BERTOZZI CAROLYN R; AGARD NICHOLAS J; PRESCHER JENNIFER A; BASKIN JEREMY MICHAEL; UNIV CALIFORNIA
摘要:The present invention provides modified cycloalkyne compounds; and method of use of such compounds in modifying biomolecules. The present invention features a cycloaddition reaction that can be carried out under physiological conditions. In general, the invention involves reacting a modified cycloalkyne with an azide moiety on a target biomolecule, generating a covalently modified biomolecule. The selectivity of the reaction and its compatibility with aqueous environments provide for its application in vivo (e.g., on the cell surface or intracellularly) and in vitro (e.g., synthesis of peptides and other polymers, production of modified (e.g., labeled) amino acids).

专利号:WO-9710221-A1
优先权日:1995-09-15
标 题:Synthesis of quinazolinone libraries
发明人:HOUGHTEN RICHARD A; OSTRESH JOHN M
权利人:TORREY PINES INST
摘要:The present invention provides synthetic combinatorial libraries of organic compounds based on the quinazolinone ring.
重庆赛维药业有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.succeway.com
电话: 86-23-68624447👤
📞重庆赛维药业有限公司 ⚠️参考联系方式

销售电话:86-23-68624447
邮箱:bgs@succeway.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


摘要:Tong, M. L.; Kunz, K.; Jaschinski, M.; Holzschneider, K.; Celik, I. E.; Kirsch, S. F., Science of Synthesis Knowledge Updates, (2020) 2, 247.
参考文献:10.1007/s003920050283
摘要:Schulze-Bahr E, Wedekind H, Haverkamp W, Borggrefe M, Assmann G, Breithardt G, Funke H. The LQT syndromes – current status of molecular mechanisms. Clinical Research in Cardiology. 1999 Apr;88(4):245–54. doi: 10.1007/s003920050283.
参考文献:10.1023/a:1007743521932
摘要:Marschang H, Beyer T, Karolyi L, Kübler W, Brachmann J. Differential rate and potassium-dependent effects of the class III agents d-sotalol and dofetilide on guinea pig papillary muscle. Cardiovasc Drugs Ther. 1998 Dec;12(6):573–83. doi: 10.1023/a:1007743521932.
参考文献:10.1007/bf02253566|10.1159/000025393
摘要:Lai L, Su M, Tseng Y, Lien W. Sensitivity of the Slow Component of the Delayed Rectifier Potassium Current (IKs) to Potassium Channel Blockers: Implications for Clinical Reverse Use-Dependent Effects. Journal of Biomedical Science. 1999 Jul 16;6(4):251–9. doi: 10.1159/000025393.
参考文献:10.1007/s00380-003-0750-8
摘要:Hiramatsu M, Wu LM, Hirano Y, Kawano S, Furukawa T, Hiraoka M. Block of HERG current expressed in HEK293 cells by the Na+-channel blocker cibenzoline. Heart Vessels. 2004 May;19(3):137–43. doi: 10.1007/s00380-003-0750-8.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知